J.C. Legrand

Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains

A. Mauborgne, F. Javoy‐Agid, J.C. Legrand et al. · Brain Research · 1983 · 149 citations

Neurodegenerative Diseases, Substantia Nigra, Neuroprotection +8

CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

Jeanne‐Marie Studler, F. Javoy‐Agid, F. Cesselin et al. · Brain Research · 1982 · 108 citations

Substantia Nigra, Neurophysiology, Neuropharmacology +8

Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain

H. Taquet, F. Javoy‐Agid, M. Hamon et al. · Brain Research · 1983 · 87 citations

Neurological Disorder, Medicine, Parkinson Disease +7

Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains

H. Taquet, F. Javoy‐Agid, F. Cesselin et al. · Brain Research · 1982 · 63 citations

Neurophysiology, Neuroanatomy, Ventral Mesencephalon +13

Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections

P Van der Auwera, Jean Klášterský, J.P. Thys et al. · Antimicrobial Agents and Chemotherapy · 1985 · 62 citations · Full text

Serum Bactericidal Activity, Antimicrobial Susceptibility, Health Sciences +13